A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 in Healthy PostMenopausal Women

Clinical trial NCT05418426 · COMPLETED

Trial details

NCT number: NCT05418426
Sponsor: Daré Bioscience, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Vulvovaginal Atrophy Vasomotor Symptoms

Start date: 2020-08-18
Primary completion: 2021-04-27
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.